Vaxirab N Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Purified chick embryo cell culture rabies vaccine (Pitman Moore Wistar strain) potency ≥2.5 IU

Indications/Uses

Pre- or post-exposure prophylaxis against rabies.

Click to view Vaxirab N detailed prescribing information

Dosage/Direction for Use

Pre-exposure vaccination 1 mL IM on days 0, 7 & 28 (or 21), given into the deltoid muscle, or in small childn, in the anterolateral thigh but never in the gluteal region. Post-exposure in incomplete or unvaccinated person Active vaccination 5 IM inj of 1 mL on days 0, 3, 7, 14 & 28 into the deltoid muscle & in the anterolateral thigh in small childn, but never in the gluteal region, or 0.1 mL intradermally. Passive immunization w/ human rabies Ig Initially, 20 IU/kg of human rabies Ig via IM. Post-exposure immunization in previously vaccinated person 2 IM doses on days 0 & 3 & do not require any rabies Ig.

Click to view Vaxirab N detailed prescribing information

Overdosage

View Vaxirab N overdosage for action to be taken in the event of an overdose.

Contraindications

Hypersensitivity.

Click to view Vaxirab N detailed prescribing information

Special Precautions

Do not administer by intravascular inj. If rabies vaccines derived from non-avian sources are not available, all necessary prep should be made to treat complications which might arise in the event of anaphylactic reaction. Pregnancy.

Click to view Vaxirab N detailed prescribing information

Use In Pregnancy & Lactation

Click to view Vaxirab N detailed prescribing information

Adverse Reactions

Transient fever, erythema multiforme.

Click to view Vaxirab N detailed prescribing information

Drug Interactions

Check the Ab titer when vaccination is undertaken during treatment w/ immunosuppressants. May attenuate the effects of the vaccine when in concomitant w/ rabies Ig. Reduced Ab formation after intradermal administration w/ chloroquine.

Click to view Vaxirab N detailed prescribing information

Caution For Usage

For caution against possible variation of physical aspect of medicine... Click to view Vaxirab N detailed prescribing information

Storage

View Vaxirab N storage conditions for details to ensure optimal shelf-life.

Description

View Vaxirab N description for details of the chemical structure and excipients (inactive components).

Action

View Vaxirab N mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Vaccines, Antisera & Immunologicals

ATC Classification

J07BG01 - rabies, inactivated, whole virus ; Belongs to the class of rabies viral vaccines.

Regulatory Classification

Presentation/Packing

Form

Vaxirab N lyo powd for vaccine 2.5 IU

Packing/Price

(1 dose + amp 1 mL (diluent) ) 1's

Vaxirab N

rabies vaccine

Manufacturer:

Zydus Lifesciences

Distributor:

Metro Drug

Marketer:

New Marketlink